Component

Eubacterium ramulus strain wK1

Context-specific entity; species, compartment and exposure are stated on each claim.

3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Luteolin degradation by E. ramulus wK1 yielded dihydrocaffeic acid.

    Eubacterium ramulus strain wK1 → Dihydrocaffeic acid / 3-(3,4-dihydroxyphenyl)propionic acid source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Anaerobic resting-cell fermentation.
    limitations
    Intervening chalcones were proposed but not detected; do not invent confirmed enzyme steps.
    nutrient_topic
    Luteolin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Luteolin / 3′,4′,5,7-tetrahydroxyflavone
    plain_language
    A smaller phenolic acid emerges downstream.
    primary_references
    Degradation of quercetin and luteolin by Eubacterium ramulus. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11722907/ · DOI 10.1128/AEM.67.12.5558-5567.2001

    Luteolin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 260–266

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Anaerobic resting-cell fermentation. · source_derived_draft · unverified_draft

    ## luteolin-microbial-end-product A smaller phenolic acid emerges downstream. Luteolin degradation by E. ramulus wK1 yielded dihydrocaffeic acid. Model: Anaerobic resting-cell fermentation. Limitations: Intervening chalcones were proposed but not detected; do not invent confirmed enzyme steps. Evidence access: Primary abstract Degradation of quercetin and luteolin by Eubacterium ramulus. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11722907/ · DOI 10.1128/AEM.67.12.5558-5567.2001
    Complete structured claim and evidence

  2. Anaerobic E. ramulus wK1 converted luteolin through an identified eriodictyol intermediate.

    Eubacterium ramulus strain wK1 → Eriodictyol source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Resting bacterial cells, HPLC and mass spectrometry.
    limitations
    Human-derived strain, not a measured conversion fraction in a person.
    nutrient_topic
    Luteolin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Luteolin / 3′,4′,5,7-tetrahydroxyflavone
    plain_language
    Gut bacteria can change the flavone scaffold.
    primary_references
    Degradation of quercetin and luteolin by Eubacterium ramulus. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11722907/ · DOI 10.1128/AEM.67.12.5558-5567.2001

    Luteolin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 252–258

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Resting bacterial cells, HPLC and mass spectrometry. · source_derived_draft · unverified_draft

    ## luteolin-microbial-first-step Gut bacteria can change the flavone scaffold. Anaerobic E. ramulus wK1 converted luteolin through an identified eriodictyol intermediate. Model: Resting bacterial cells, HPLC and mass spectrometry. Limitations: Human-derived strain, not a measured conversion fraction in a person. Evidence access: Primary abstract Degradation of quercetin and luteolin by Eubacterium ramulus. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11722907/ · DOI 10.1128/AEM.67.12.5558-5567.2001
    Complete structured claim and evidence

  3. E. ramulus degraded luteolin 7-glucoside but not luteolin 5-glucoside under the tested anaerobic conditions.

    Eubacterium ramulus strain wK1 → Luteolin 7-O-glucoside source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Bacterial substrate-degradation study.
    limitations
    Not evidence that all gut communities behave identically.
    nutrient_topic
    Luteolin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Luteolin / 3′,4′,5,7-tetrahydroxyflavone
    plain_language
    Changing sugar position changed bacterial access.
    primary_references
    Anaerobic degradation of flavonoids by Eubacterium ramulus. · 2000 · https://pubmed.ncbi.nlm.nih.gov/10648107/ · DOI 10.1007/s002030050010

    Luteolin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 268–274

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Bacterial substrate-degradation study. · source_derived_draft · unverified_draft

    ## luteolin-microbial-glucoside-selectivity Changing sugar position changed bacterial access. E. ramulus degraded luteolin 7-glucoside but not luteolin 5-glucoside under the tested anaerobic conditions. Model: Bacterial substrate-degradation study. Limitations: Not evidence that all gut communities behave identically. Evidence access: Primary abstract Anaerobic degradation of flavonoids by Eubacterium ramulus. · 2000 · https://pubmed.ncbi.nlm.nih.gov/10648107/ · DOI 10.1007/s002030050010
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards